defenseworld.net · Dec 3, 2025
Head to Head Contrast: Petros Pharmaceuticals (NASDAQ:PTPI) vs. Statera Biopharma (NASDAQ:STAB)
Profitability This table compares Statera Biopharma and Petros Pharmaceuticals' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Statera Biopharma N/A N/A N/A Petros Pharmaceuticals N/A -78.22% -23.50% Insider and Institutional Ownership 12.3% of Petros Pharmaceuticals shares are owned by institutional investors. 5.5% of Statera Biopharma shares
